Simplify Propel Opportunities ETF Rating $16.18 +0.27 (+1.67%) Closing price 03:50 PM EasternExtended Trading$16.18 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SURI Aggregate RatingModerate Buy 2.61Holdings in SURI have an aggregate rating of Moderate Buy based on 92 analyst ratings issued in the past year covering 15 companies (91.7% of the portfolio).SURI Aggregate Price Target$16.13-0.28% DownsideHigh Prediction$16.13Average Prediction$16.13Low Prediction$16.13Holdings in SURI have an aggregate price target of $16.13 and a range of $16.13 to $16.13 covering 15 companies (91.7% of the portfolio).SURI Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy5 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Propel Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 15 SURI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings35.61%PAGPPlains GP$19.24+1.2%2.1451 of 5 stars2.25$20.50 6.5%8Positive NewsDividend AnnouncementAnalyst Forecast10.32%AKROAkero Therapeutics$46.94-2.6%4.0808 of 5 stars3.00$81.57 73.8%8News CoveragePositive News7.23%MISTMilestone Pharmaceuticals$1.81+2.3%1.7048 of 5 stars2.25$5.00 176.2%45.38%ABEOAbeona Therapeutics$6.88-0.3%4.4208 of 5 stars3.00$19.50 183.4%54.95%PHATPhathom Pharmaceuticals$12.36-0.6%2.5587 of 5 stars3.00$17.50 41.6%64.59%CASHPathward Financial$80.12+0.1%3.7084 of 5 stars2.50$91.00 13.6%2Positive NewsDividend Announcement4.42%ACHVAchieve Life Sciences$3.16+6.0%2.0563 of 5 stars3.50$14.67 364.1%4Positive NewsAnalyst RevisionHigh Trading Volume4.26%DCTHDelcath Systems$10.88-0.5%2.8736 of 5 stars3.00$24.50 125.2%4Positive News3.12%CLDXCelldex Therapeutics$22.38-1.0%1.7399 of 5 stars2.78$46.67 108.5%92.97%APLTApplied Therapeutics$0.51+1.5%4.1318 of 5 stars2.50$6.10 1,093.0%6News CoveragePositive News2.72%TCRXTScan Therapeutics$1.82-2.7%3.1811 of 5 stars3.00$7.80 328.6%52.03%ZVRAZevra Therapeutics$9.30-0.6%3.3893 of 5 stars3.00$23.71 155.0%101.83%CMPSCOMPASS Pathways$4.81+1.9%2.4069 of 5 stars2.86$16.29 238.6%7News CoveragePositive News1.38%VRDNViridian Therapeutics$18.44-0.6%1.9251 of 5 stars2.90$37.78 104.9%10News CoveragePositive NewsAnalyst Forecast0.85%ATHAAthira Pharma$0.40-1.1%3.7498 of 5 stars2.00$0.50 26.4%4Positive News This page (NYSEARCA:SURI) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Propel Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Propel Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access